BPA Call HT942523A0016-HT942524F0194

Award Date 6/11/24
Potential Completion Date 6/11/24
Potential Value $176K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency (DHA) has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Verogen, Inc. for the provision of testing reagents and consumables to support the agency's genomic sequencing initiatives. The contract, valued at $46,967.19, is for the delivery of products such as MiSeq reagent kits, NextSeq systems, and ForenSeq kits. This BPA, which has no set-aside designation, was originally awarded to Verogen in November 2023 and runs through October 2028. Verogen, a...
This contract was awarded by the Defense Health Agency to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The $153,135.25 Blanket Purchase Agreement (BPA) Call is for the delivery of MiSeq Reagent Kits, a type of next-generation sequencing consumable. The contract is a firm fixed-price vehicle without a small business set-aside designation. Verogen has previously supported the Defense Health Agency, Federal Bureau of Investigation, U.S. Army...
This is a firm fixed price BPA call order awarded by the Defense Health Agency to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The contract is for the delivery of 200 units of the MiSeq Reagent Kit, a product used in next-generation DNA sequencing, with a potential value of $328,339.49 and a completion date of August 2, 2023. Verogen has previously provided sequencing systems, reagents, and technical services to support the Defense Health...
The Defense Health Agency has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing. This $81,521.36 contract provides the agency with ForenSeq mitochondrial DNA (mtDNA) whole genome sequencing kits and consumables to support its genomic sequencing initiatives. Verogen holds a $7,433,000 single-award BPA with the Defense Health Agency, awarded in November 2023, to supply a range...
This federal contract award is for the supply of REAGENT KITS to the Defense Health Agency (DHA), a component of the U.S. Department of Defense. The prime contractor is Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The contract is a Blanket Purchase Agreement (BPA) Call with a ceiling value of $88,695.32 and a performance period ending on March 27, 2025. The contract is a Firm Fixed Price arrangement and does not utilize any small business...
This is a firm fixed price BPA call contract awarded by the Defense Health Agency to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The contract is for the delivery of MiSeq sequencing systems, ForenSeq reagent kits, next-generation sequencing reagents and consumables, and technical support services, with a potential value of $117,480.37. Verogen has previously provided similar products and services to federal agencies such as the FBI, Army...
This firm fixed-price contract award to Verogen, Inc. by the Defense Health Agency is a BPA call order valued at $225,050.22. It does not have a set-aside designation. The contract is for the procurement of MiSeq RGT KIT V3 (150) sequencing reagents and consumables to support the agency's genomic sequencing programs. Verogen is a biotechnology company that specializes in forensic genomics and DNA sequencing, and has previously provided similar products and services to federal agencies such as...
This contract award to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing, was made by the Defense Health Agency. The $45,483.03 firm-fixed-price contract provides for the delivery of ForenSeq Kintelligence KT reagents, which are used in next-generation DNA sequencing systems. This is a Blanket Purchase Agreement (BPA) call, part of a larger $7,433,000 single-award BPA that Verogen holds with the Defense Health Agency. The BPA allows the agency...
This is a firm fixed-price contract awarded by the Defense Health Agency to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing. The contract, valued at $413,414.01, is for the provision of MiSeQ RGT V3 sequencing systems, reagents, consumables, and technical support services. The contract is a Blanket Purchase Agreement (BPA) call, which allows the agency to procure standardized laboratory supplies to support its genomic sequencing programs....
This is a firm fixed price contract awarded by the Defense Health Agency to Verogen, Inc., a biotechnology research company that specializes in forensic genomics and DNA sequencing. The contract has a potential value of $235,984.48 and does not have a set-aside designation. Through this contract, Verogen will provide the Defense Health Agency with various products and services related to next-generation DNA sequencing, including MiSeq FGx sequencing systems, ForenSeq reagent kits, sequencing...
  • HT942523A0016
    Blanket Purchase Agreement
  • HT942523A0016-HT942524F0194
    BPA Call

This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The contract is for the provision of MiSeq Reagent Kit v2, which are consumables used in the agency's genomic sequencing initiatives. The BPA has a ceiling value of $175,816.60 and a period of performance through June 11, 2024. This award is part of a larger single-award BPA contract with Verogen that was originally established in November 2023 with a ceiling value of $7,433,000, allowing the DHA to efficiently acquire standardized laboratory supplies for its ongoing research and operational needs in forensic genomics and DNA analysis. The contract does not have a small business set-aside designation.

Generated 8/28/24, 11:53 AM